Table 3 Apolipoprotein levels in... | American Society of Hematology

Table 3

Apolipoprotein levels in patients with sickle cell disease and healthy African-American control subjects

Sex/ group	n	apoA-I	apoB	apoB/apoA-I ratio
Males
SCD	127	.98 (.90, 1.15)*†	.58 (.47, .72)‡§	0.57 (0.47, 0.78)
Control	15	1.33 (1.15, 1.50)	.89 (.72, 1.05)	0.70 (0.56, 0.73)
Females
SCD	153	1.13 (.98, 1.32)*	.65 (.52, .80)‡	0.58 (0.47, 0.72)
Control	35	1.43 (1.30, 1.56)	.79 (.65, .90)	0.53 (0.44, 0.71)

Sex/ group	n	apoA-I	apoB	apoB/apoA-I ratio
Males
SCD	127	.98 (.90, 1.15)*†	.58 (.47, .72)‡§	0.57 (0.47, 0.78)
Control	15	1.33 (1.15, 1.50)	.89 (.72, 1.05)	0.70 (0.56, 0.73)
Females
SCD	153	1.13 (.98, 1.32)*	.65 (.52, .80)‡	0.58 (0.47, 0.72)
Control	35	1.43 (1.30, 1.56)	.79 (.65, .90)	0.53 (0.44, 0.71)

Apolipoprotein levels are expressed in g/L.

P < .001 compared with same-sex controls;

P < .001 compared with SCD females;

P = .001, compared with same sex controls;

P = .01, compared with SCD females; Mann-Whitney test.